Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jul 14, 2026

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material
11:12

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material

Published on: August 1, 2018

Transcriptomic signatures in breast cancer.

Jianjiang Fu1, Stefanie S Jeffrey

  • 1Stanford University Medical Center, Stanford, CA 94305-5494, USA.

Molecular Biosystems
|June 21, 2007
PubMed
Summary

High throughput DNA microarray technology aids breast cancer research, classifying subtypes and predicting outcomes. Further standardization and collaborative studies are needed for full clinical impact.

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA (lncRNA)...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Integrative analysis of small cell carcinoma of the uterine cervix reveals its heterogeneity and provides novel predictive markers.

Cancer immunology, immunotherapy : CII·2026
Same author

Inhibition of protein translational machinery in triple-negative breast cancer as a promising therapeutic strategy.

Cell reports. Medicine·2024
Same author

Nudifloside, a Secoiridoid Glucoside Derived from Callicarpa nudiflora, Inhibits Endothelial-to-Mesenchymal Transition and Angiogenesis in Endothelial Cells by Suppressing Ezrin Phosphorylation.

Journal of Cancer·2024
Same author

Artificial intelligence in cancer pathology: Challenge to meet increasing demands of precision medicine.

International journal of oncology·2023
Same author

Rapid genetic screening with high quality factor metasurfaces.

Nature communications·2023
Same author

Combining Acoustic Bioprinting with AI-Assisted Raman Spectroscopy for High-Throughput Identification of Bacteria in Blood.

Nano letters·2023

Area of Science:

  • Genomics
  • Oncology
  • Bioinformatics

Background:

  • High throughput DNA microarray technology is widely used in breast cancer research.
  • Applications include molecular subtyping, outcome prediction, and identifying therapeutic targets.

Purpose of the Study:

  • To assess the current state and future needs of DNA microarray technology in breast cancer research.
  • To highlight challenges and requirements for clinical implementation.

Main Methods:

  • Review of DNA microarray applications in breast cancer studies.
  • Discussion of standardization, clinical trial design, and bioinformatic approaches.

Main Results:

  • Microarray technology shows promise for breast cancer classification and treatment prediction.
  • Significant challenges remain, including the need for technique standardization and robust clinical trial design.

Conclusions:

  • Collaborative, multi-institutional studies are essential for statistical power due to breast cancer heterogeneity.
  • Advancements in bioinformatics are crucial for analyzing complex microarray data and realizing the technology's full potential in clinical practice.

Related Experiment Videos

Last Updated: Jul 14, 2026

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material
11:12

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material

Published on: August 1, 2018